- Stories /
- Healthcare /
- Quintiles /
![Quintiles image](/media/jdudiuwq/picture1.png?width=616&height=370&v=1d9b0220b91ee30)
![Quintiles NEW](/media/3x3fsuzl/quintiles_new.png?width=198&height=66&v=1d9b6511f3455b0)
Transformational growth to become the world’s largest provider of life sciences product development and integrated healthcare services
![USA Flag New 05](/media/rgcld0l3/usa_flag_new-05.png?width=50&height=50&v=1d9b33b33b2ab90)
2008 - 2016
Good to great
250%
EBITDA increased from $370m to $830mNear doubling of revenue from $2.8bn to $4.5bn; EBITDA grew over 250%
75%
growth in employee numbersExpanded the global employee base from c.20,000 to c.35,000 employees
9
acquisitions during ownershipOperates in over 100 countries
Listed on the NYSE in May 2013, becoming a member of the FORTUNE 500, and named in FORTUNE’s list of the “World’s Most Admired Companies”